Scaling molecular glue discovery with AI-driven design and prediction
3:30 pm - Thursday 28th January 2027
- Combining AI, machine learning, and computational modelling to identify productive target-ligase interactions and enable more rational molecular glue discovery
- Advancing a diverse pipeline of degraders, activators, and RIPTACs across neurodegeneration, fibrosis, oncology, and other disease areas
- Leveraging an integrated discovery platform to accelerate hit identification, improve candidate quality, and unlock previously inaccessible biology
